LEGAL DISCLAIMER: THIS ANNOUNCEMENT IS FOR INFORMATIONAL PURPOSES ONLY. NEITHER THE GDA NOR THE ADA ENDORSES THIS STUDY OR OTHERWISE RECOMMENDS/REQUIRES THAT MEMBERS PARTICIPATE IN THE CLINICAL TRIALS. PARTICIPATION IN THE STUDY IS STRICTLY VOLUNTARY. 

Clinical trials for the COVID-19 vaccine currently under development by Moderna are currently underway in Georgia. Due to their high occupational exposure risk, volunteers from the dental profession are being asked to participate in the study, which is strictly voluntary in nature. For more details on the study and to register as a participant, please visit: https://www.coronaviruspreventionnetwork.org/.

Moderna’s mRNA-1273 vaccine, The COVE Study^™  

The mRNA-1273 vaccine is being developed to prevent COVID-19. The purpose of this study is to test Moderna’s vaccine candidate to see if it can prevent illness if people are exposed to the SARS-CoV-2 virus in their everyday lives. The mRNA-1273 vaccine is not made from the SARS-CoV-2 virus. It is made from messenger ribonucleic acid (mRNA), a genetic code that tells cells how to make protein, which helps the body’s immune system make antibodies to fight the virus. The vaccine cannot cause infection or make someone sick with COVID-19.